Diplomat to dispense Cuvitru

FLINT, Mich. — Diplomat Pharmacy announced Monday that it had begun filling prescriptions for Shire’s Cuvitru, which launched last week following its September approval by the Food and Drug Administration. The drug treats primary humoral immunodeficiency in patients ages 2 years and older. 

 

"We are excited to offer patients a therapy that expands their options for treating primary immunodeficiency," Diplomat president Paul Urick said. "Cuvitru is an important treatment for patients with unmet needs."

 

There are more than 300 primary immunodeficiency disorders, in which a part of the immune system is missing or does not function properly. Cuvitru is a ready-to-use injection solution administered via subcutaneous infusion only.